Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Isoflurane for Sedation in Cardiogenic Shock Patients on ECMO
NCT07099014Phase 3Not yet recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2025
- Primary completion
- Oct 2028
- Modality
- Allosteric Modulators
01
Overview
A Phase 3 trial of isoflurane in cardiogenic shock, sponsored by Assistance publique - Hôpitaux de Paris. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
isoflurane
03
Conditions
cardiogenic shock
Beyond the preview
Go deeper on NCT07099014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07099014.